These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9165226)
1. Activated platelets in subjects at increased risk of IDDM. DENIS Study Group. Deutsche Nikotinamid Interventionsstudie. Tschoepe D; Driesch E; Schwippert B; Lampeter EF Diabetologia; 1997 May; 40(5):573-7. PubMed ID: 9165226 [TBL] [Abstract][Full Text] [Related]
2. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Tschoepe D; Driesch E; Schwippert B; Nieuwenhuis HK; Gries FA Diabetes; 1995 Aug; 44(8):890-4. PubMed ID: 7542611 [TBL] [Abstract][Full Text] [Related]
4. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Konijnenberg A; van der Post JA; Mol BW; Schaap MC; Lazarov R; Bleker OP; Boer K; Sturk A Am J Obstet Gynecol; 1997 Aug; 177(2):434-42. PubMed ID: 9290465 [TBL] [Abstract][Full Text] [Related]
5. PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS). Kolarov P; Tschoepe D; Nieuwenhuis HK; Gries FA; Strauer B; Schultheiss HP Eur Heart J; 1996 Aug; 17(8):1216-22. PubMed ID: 8869863 [TBL] [Abstract][Full Text] [Related]
6. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Konijnenberg A; Stokkers EW; van der Post JA; Schaap MC; Boer K; Bleker OP; Sturk A Am J Obstet Gynecol; 1997 Feb; 176(2):461-9. PubMed ID: 9065199 [TBL] [Abstract][Full Text] [Related]
7. Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Tschoepe D; Spangenberg P; Esser J; Schwippert B; Kehrel B; Roesen P; Gries FA Cytometry; 1990; 11(5):652-6. PubMed ID: 1696196 [TBL] [Abstract][Full Text] [Related]
8. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Lampeter ER; Kishimoto TK; Rothlein R; Mainolfi EA; Bertrams J; Kolb H; Martin S Diabetes; 1992 Dec; 41(12):1668-71. PubMed ID: 1280239 [TBL] [Abstract][Full Text] [Related]
9. Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P selectin (CD62) and GP53 (CD63). Cahill MR; Macey MG; Newland AC Br J Haematol; 1993 Jul; 84(3):527-9. PubMed ID: 7692932 [TBL] [Abstract][Full Text] [Related]
10. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie. Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004 [TBL] [Abstract][Full Text] [Related]
11. Large platelets continue to circulate in an activated state after myocardial infarction. Schultheiss HP; Tschoepe D; Esser J; Schwippert B; Roesen P; Nieuwenhuis HK; Schmidt-Soltau C; Strauer B Eur J Clin Invest; 1994 Apr; 24(4):243-7. PubMed ID: 7519556 [TBL] [Abstract][Full Text] [Related]
12. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Tschoepe D; Schultheiss HP; Kolarov P; Schwippert B; Dannehl K; Nieuwenhuis HK; Kehrel B; Strauer B; Gries FA Circulation; 1993 Jul; 88(1):37-42. PubMed ID: 7686453 [TBL] [Abstract][Full Text] [Related]
13. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610 [TBL] [Abstract][Full Text] [Related]
14. The postmortem activation status of platelets. Thomsen H; Krisch B Int J Legal Med; 1994; 107(3):111-7. PubMed ID: 7534469 [TBL] [Abstract][Full Text] [Related]
15. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848 [TBL] [Abstract][Full Text] [Related]
17. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests. Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies. Fanelli A; Bergamini C; Rapi S; Caldini A; Spinelli A; Buggiani A; Emmi L Lupus; 1997; 6(3):261-7. PubMed ID: 9104734 [TBL] [Abstract][Full Text] [Related]
19. Platelet activation markers in patients with venous thromboembolism without predisposing factors. Gerdsen F; Weber M; Langer F; Eifrig B; Lindhoff-Last E Pathophysiol Haemost Thromb; 2005; 34(1):1-5. PubMed ID: 16293978 [TBL] [Abstract][Full Text] [Related]